Our 6 ‘Best Buys Now’ Shares Royston Wild | Tuesday, 23rd June, 2020 | More on: DLG GSK Click here to claim your copy now — and we’ll tell you the name of this Top US Share… free of charge! Renowned stock-picker Mark Rogers and his analyst team at The Motley Fool UK have named 6 shares that they believe UK investors should consider buying NOW.So if you’re looking for more stock ideas to try and best position your portfolio today, then it might be a good day for you. Because we’re offering a full 33% off your first year of membership to our flagship share-tipping service, backed by our ‘no quibbles’ 30-day subscription fee refund guarantee. Enter Your Email Address Image source: Getty Images. Simply click below to discover how you can take advantage of this. Don’t know what stocks to buy? I’d buy cheap FTSE 100 shares in an ISA These are perplexing times for FTSE 100 investors. Buy shares today and run the risk of them collapsing in value on Covid-19 worries? Or hold off and miss some of the ‘opportunities of a lifetime’ that we hear so much about?It’s true that the macroeconomic and geopolitical landscape is fraught with danger. You don’t just need to consider the potential impact that the coronavirus could have on your investments. Mixed signals coming out of the White House on US-Chinese trade relations are another serious problem facing the world economy, and with them the outlook for global share markets.5G is here – and shares of this ‘sleeping giant’ could be a great way for you to potentially profit!According to one leading industry firm, the 5G boom could create a global industry worth US$12.3 TRILLION out of thin air…And if you click here we’ll show you something that could be key to unlocking 5G’s full potential…Could it be argued that these colossal risks are baked into the valuations of many FTSE 100 stocks though? I certainly believe so. There are clearly some possible short-to-medium term obstacles that investors need to consider. But there are many, many stocks which, despite these imminent uncertainties still have bright long-term futures. And at current prices many of them are too cheap to miss.One FTSE 100 bargainGlaxoSmithKline’s (LSE: GSK) one FTSE 100 stock that’s worthy of serious attention at recent prices. It trades on a forward P/E ratio of below 15 times and carries a dividend yield of 5% to boot, too.Even the most risk-averse of investors should be attracted to Glaxo, I feel. Economic factors don’t alter the fact that medicines are essential commodities. Investors here don’t really need to worry about Covid-19 consequences, trade wars and the like.Instead, shareholders can look forward to ripping profits growth over the coming decade as its bulging pipeline of blockbuster products delivers. Glaxo’s revenues jumped almost 20% in the first quarter as sales of products like Trelegy and Nucala rocketed. Soaring revenues pay tribute to the company’s focus on fast-growing therapy areas like respiratory, vaccines and oncology too.The 9% dividend yieldNow, Direct Line Insurance Group (LSE: DLG) isn’t on the index of Britain’s top 100 shares. It came within a whisker of being promoted from the FTSE 250 in the most recent FTSE 100 reshuffle, however. And it could still be elevated to the prestigious blue-chip index before long.I reckon the insurance giant is a top value share for both growth and income investors. As well as a forward P/E multiple of around 11 times, Direct Line sports a monster dividend yield just shy of 9%. It shares the same sort of near-term protection as Glaxo in that insurance demand doesn’t tend to falter significantly during economic downturns. In fact, in the case of motor insurance — the company’s single most important product segment — it’s something that we are legally obliged to buy whatever the weather.But this isn’t why I’d buy Direct Line shares today. I’m encouraged by the huge investment it’s made in marketing its brands, a strategy that helped total gross written premiums rise 5% in the first quarter. And I like the insurer’s intense cost-cutting drive to create a leaner earnings-creating machine in the future. “This Stock Could Be Like Buying Amazon in 1997” I’m sure you’ll agree that’s quite the statement from Motley Fool Co-Founder Tom Gardner.But since our US analyst team first recommended shares in this unique tech stock back in 2016, the value has soared.What’s more, we firmly believe there’s still plenty of upside in its future. In fact, even throughout the current coronavirus crisis, its performance has been beating Wall St expectations.And right now, we’re giving you a chance to discover exactly what has got our analysts all fired up about this niche industry phenomenon, in our FREE special report, A Top US Share From The Motley Fool. See all posts by Royston Wild I would like to receive emails from you about product information and offers from The Fool and its business partners. Each of these emails will provide a link to unsubscribe from future emails. More information about how The Fool collects, stores, and handles personal data is available in its Privacy Statement. Royston Wild has no position in any of the shares mentioned. The Motley Fool UK owns shares of and has recommended GlaxoSmithKline. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.
- State Pension worries? I think investing £100 a month in UK shares could help you retire in comfort
- Can you really survive on the State Pension alone?